Blog

Dana-Farber/Boston Children’s ranked among the best pediatric cancer programs in the nation for 18th year in a row

dana-farber.org

Oct 9, 2024, 12:04

Dana-Farber/Boston Children’s ranked among the best pediatric cancer programs in the nation for 18th year in a row

Dana-Farber/Boston Children’s Hospital Cancer and Blood Disorder Center has been recognized as one of the top three pediatric cancer centers in the United States by U.S. News and World Report, continuing their legacy since 2007.

On this occasion, Dana-Farber/Boston Children’s Hospital shared a post on LinkedIn:

“We are proud to announce that Dana-Farber/Boston Children’s Hospital Cancer and Blood Disorder Center has again been name among the best pediatric cancer hospitals in the United States by U.S. News and World Report. Dana-Farber/Boston Children’s has been recognized as one of the top three pediatric cancer centers in the country each year since the ranking’s inception in 2007.

‘We are honored that U.S. News and World Report has recognized our program among the top pediatric cancer programs in the country and as the top program in New England for the past 18 years and we are proud to continue providing exceptional patient care and conducting impactful research,’ said Scott Armstrong, President of Dana-Farber/Boston Children’s.”

Andrew Place, Vice President, Pediatric Chief Medical Officer of Dana-Farber/Boston Children’s Cancer and Blood Disorders Center said, “This success is a testament to our dedicated doctors, nurses, and workforce who provide exceptional clinical care and world-class research that is changing how we treat children and adolescents with cancer.”

Dana-Farber/Boston Children’s brings together two internationally recognized research and teaching institutions that have provided comprehensive care for pediatric oncology and hematology patients since 1947. The Harvard Medical School affiliates share a clinical staff that delivers inpatient care and surgery at Boston Children’s and most outpatient care at Dana-Farber Cancer Institute.

David Williams, Chief, Division of Hematology/Oncology, Boston Children’s Hospital, and Leland Fikes Professor of Pediatrics at Harvard Medical School said, “The program at Dana-Farber/Boston Children’s is unique, as it brings together the expertise of a world-class cancer center and an internationally renowned children’s hospital to provide specialized care to children affected by cancer and blood disorders. This ranking recognizes the personalized treatment approaches we are able to deliver to all our patients.”

Read further.

Dana-Farber Cancer Institute, located in Boston, Massachusetts, is a leading institution for cancer treatment and research. It was founded by Sidney Farber on 1947. Currently, the Institute has over 5,000 staff, faculty, and clinicians on board. They manage in excess of 640,000 outpatient visits each year, oversee more than 1,000 hospital discharges annually, and are actively involved in over 1,100 ongoing clinical trials.

As of 2023, Dana-Farber is ranked as the #4 cancer hospital globally. Dana-Farber’s research contributions include the development of Gleevec, a highly successful treatment for chronic myeloid leukemia.